Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great thank you. My dad had the knee done in June and has done awesome. Home 2 days post surgery. It's amazing
I believe they will resubmit before 2017. What I have been hearing is they are still testing components and may resubmit in October.
Have you heard anything on the Hip
I hope they resubmit the hip again soon. Then to the moon!
I am going to add around here (6.21) but going to see if it hits lower first.. this is ridiculous. My future self is going to thank me.
Picked up a bunch more at 7.00 on the 14th. No real reason for the dip. 500+ patents still. Hips coming soon. Knees doing well!
A nice run up!
Added some this AM 6.02
Nice avg down :)
* * $CFMS Video Chart 05-16-16 * *
Link to Video - click here to watch the technical chart video
Bouncy bounce! Missed my entry fill by a freakin nickel but she did bounce. Still keeping an eye on this one. GLTA
It is definitely oversold.. The company is doing just fine.. the CEO will be replaced, likely for someone better. This will get back up there, it will just likely take more time now, probably in 2017 will it start to show kind numbers.
Now is a great entry though. There was not another recall, they arent doing bad. Surgeons still like them based on existing patients and their feedback.
It is still the #1 joint replacement technology. They still have around 500 patents!
Buying in at this price is going to give you a nice future.
I agree it's way over sold. I wish I had some capital to put into the company, I would I a heart beat.
Just started a position. The selloff seems just a tad overdone?
Down almost 50% because projected sales were off 8%?
... and I guess the downgrades and CEO replacement, too.
Still, seems over done. Company is in good shape with over $100M in cash
and near zero debt ( $400k ).
Going in for the possible dead cat.
This one sure got beat up today in for a bit at 5.13 $
Conformis CEO will be on MAD MONEY with Jim Cramer tonight.
Dr. Moby Parsons and Dr. David Thut of Seacoast Orthopedics & Sports Medicine discuss patient specific knee replacement surgery at a community lecture held at Wentworth-Douglass Hospital on 3.23.16.
The latest news release was not necessarily negative. They will resubmit to the FDA in time, when they get their ducks in a row.
They will now focus on one of their alternate knee replacements (PS) which is one of their moving products.
Another good day so far.. Lets hope this keeps up after lunch!
ConforMIS Announces Positive Results from Clinical Studies Comparing the ConforMIS iTotal® CR to Leading “Off-The-Shelf” Total Knee Replacement Products
http://www.conformis.com/conformis-announces-positive-results-from-clinical-studies-comparing-the-conformis-itotal-cr-to-leading-off-the-shelf-total-knee-replacement-products/
Now this is what I am talking about! Positive results VS leading competitors!
This is the start of the news we needed :)
More positive news ahead guys! Just wait ;)
CFMS!!!!!!!!!
CFMS!!!!!!!!!
Between the recall, this still being a relatively new ticker, its competitors, new tech and the general market direction lately.. I am not surprised.
Give CFMS time. More positive news coming, their track record should improve, trust will build, PPS will rise.
Get on board, now is the time. Make the initial investment count!
Spot on, Degenerate! Hopefully sooner than later.. Next financials should be better and the next better still. As you said, there is no reason for this PPS.
I agree, sh4dow. This company will continue to take market share from the bigger knee replacement companies because CFMS has the better product. This information will spread throughout the medical community and cause sales to increase. This is inevitable! There is no reason why the share price is below the IPO price. The dark clouds created by political hype has caused medical device companies to not be wanted by the market. This temporary setback will soon go away as the election rhetoric concentrates on other matters (hopefully).
Instead of an off the shelf knee implant, Conformis makes 6 slight variations of the implant at very minor differences in measurement.
The surgeon selects the best fitting implant and then performs the surgery. This is partly why the post surgery results are so good with conformis replacement knees vs the others.
Due diligence pays out in the end!
There should be news at some point soon. I believe they are doing new things and next Q should be nice.
This is frustrating because there is no reason this keeps happening. This is a solid company with solid performance. All it needs is a little time and we are golden.
Whoops got my days confused lol.. Are you ready TODAY??
Are you guys ready for the ER today?? Kind of excited..
So much fear in the air, do you smell it? I am buying it.
FEBRUARY 11TH EARNINGS REPORT
I am hoping there is some interest that starts accumulating here after the ER.. Either it will be positive and PPS will reflect OR it will not be so good.
It depends if they had attorney on retainer or if they hired one specifically for the lawsuit.
Dont forget, with all the crossfit warriors adopting this trend of work outs there will be an amazing number of people needing joint replacements.
Think about this. Crossfit is relatively new (around 5+ years). Between people destroying their joints with crossfit and people living longer, joint replacements are definitely going to increase in numbers.
source: https://www.google.com/webhp?sourceid=chrome-instant&ion=1&espv=2&ie=UTF-8#q=crossfit%20and%20joint%20damage
CFMS is trading at 10.71 as I write this and I believe their IPO was 15 and then traded for 18, going up from there. If it wasnt for that BS lawsuit it would have held that range.
ConforMIS is currently the leading joint replacement tech on the market and they have 500+ patents on their tech!
I almost cant believe how little interest I have seen amongst traders for this ticker.
Hopefully their earnings / financials on FEB 11th changes that around a bit.
I forgot the mention.. Johnson and Johnson recently cut around 3000 jobs across USA and decided to do some restructuring which usually follows cuts this size.. however this seemed interesting:
"The restructuring focuses on the company's orthopedics, surgery and cardiovascular businesses. It won't affect consumer medical devices, pharmaceuticals or consumer businesses."
I am thinking with Conformis' 400 something patents in this field and the current PPS, could J&J be thinking acquisition?
Source:
http://bigstory.ap.org/article/545ba7264ff742d9ad04310022d65e94/johnson-johnson-cut-about-3000-jobs-medical-devices
Well I believe the reason this started tanking before the whole market generally started was because of the millions of restricted shares that had just passed the 180 day limitation. Then the market guided it down the rest of the way.
The company is going to be reporting Financials soon (Feb 11th) and we should see some gain from that, though it will likely be limited due to market conditions.
Between the rip from financials (forward looking) and then market recovery (in time) I think the current price is amazing for long entry.
Thoughts?
One would have thought, with the recall behind them, that it would have settled in nicely. But WOW!!!! What a tank job the last few.
I think I have to add here, I mean come on...
Yes, but only as a curiosity. I saw an iTotal knee implanted yesterday. It is some impressive tech. However, It is a lot of moving parts for a tibial component. I haven't seen their data, but I imagine there would be some backside micro motion at higher rates than some competitors. Other than that, very cool patient specific knee.
It looks like a nice plateau has formed at $25 for a while (maybe a week or two), then watch for the next leg up to the $30s. Did you buy yet? Did you tell your friends yet? What are you waiting for? I will check back in a couple of weeks to continue the forecasts (and to remind you of the low prices you could have bought in at).
DeGen
As this stock hovered in the 21-22 range I highly recommended buying some and most of all telling your friends to buy some as well. Now a couple of weeks later, it's in the 25's after a nice article comes out touting the virtues of the medical equipment the company makes. iMO, this is still only the beginning of the story and the share price climb. Buying at 25 is still a great opportunity to make money over the next year or two. It would not surprise me to see the 30's before the end of the year and the 40-50's in 2016. Why would anyone pass up a good shot at a double?
DeGen
ps. Am I posting to myself? If so, no harm, because in the future I like to go back and show everyone how right I was and how they missed out.
You guys have all weekend to tell your friends about this great stock I hope to see 22s this coming week as it recovers from that unjustified drop last Thursday.
I was very shocked and disappointed to see tha SP fall 5% from $22ish to $21ish yesterday. Hard to believe with a stock such as this with such bright future and a great potential to increase profis,t the SP would fall 5% in one day. I can only believe it was those initial investors in at $15 jumping ship and booking the quick profit. They are not thinking long term like me. The profit from the best knee replacement on the market will without fail, start to increase the SP in the future.
I watched Cramer again tonight and although he talked in generalities not mentioning specific stocks, he said one should look for a company that profits would increase which then in turn cause the share price to increase. Of all the the stocks I own, Comformis came to mind immediately. Since this company is so new and has yet to report financials, any increases in profits year over year will not be seen for a while. But when the analysts start covering this stock and looking into its earning power, they will start rating it as strong buy.
Buying now, may be ahead of the curve, but one cannot know exactly when the stock will take off, but take off it will as the profits start rolling in, in an ever increasing manner. I would rather be early and not miss any of the growth, then only catch a portion of it.
DeGen
I too saw Cramer and put this on my buy list looking for a dip. Got in a couple of days ago and expect this is a keeper for several years as the company grabs more and more market share and the SP rises with the increased profits. Or gets bought out at a 20-25% premium above its share price. The company with the best product will prevail eventually. Companies like this are a rare find and being in the ever growing medical field makes this a guaranteed winner. Tell your friends, you will not be sorry.
Followers
|
16
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
373
|
Created
|
07/02/15
|
Type
|
Free
|
Moderators |
About ConforMIS, Inc.
"ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient's unique anatomy. ConforMIS offers a broad line of customized knee implants and pre-sterilized, single-use instruments delivered in a single package to the hospital. In recent clinical studies, ConforMIS iTotal CR demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. ConforMIS owns or exclusively in-licenses approximately 500 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints.
For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at http://ir.conformis.com/."
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |